Processing

Please wait...

Settings

Settings

Goto Application

1. WO2021055621 - PLASMA KALLIKREIN INHIBITORS AND USES THEREOF

Publication Number WO/2021/055621
Publication Date 25.03.2021
International Application No. PCT/US2020/051293
International Filing Date 17.09.2020
IPC
C07D 471/04 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
471Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/-C07D463/251
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
A61P 9/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
A61P 29/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs)
A61K 31/437 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
4353ortho- or peri-condensed with heterocyclic ring systems
437the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
Applicants
  • TAKEDA PHARMACEUTICAL COMPANY LIMITED [JP]/[JP]
Inventors
  • PAPAIOANNOU, Nikolaos
  • TRAVINS, Jeremy Mark
  • FINK, Sarah Jocelyn
  • ELLARD, John Mark
  • RAE, Alastair
Agents
  • JUDA, Cristin E.
  • ADAMS, Melissa M.
  • ADATO, Ronen
  • AUGST, Alexander
  • BUTEAU, Kristen C.
  • BYCHOWSKI, Meaghan E.
  • D'AMATO, Erica M.
  • DAUKSS, Dana M.
  • FLYNN, Peter A.
  • HAULBROOK, William R.
  • JARRELL, Brenda Herschbach
  • LI, Xiaodong
  • LYON, Charles E.
  • MA, Longle
  • MEDINA, Rolando
  • MONROE, Margo R.
  • PACE, Nicholas J.
  • POLIO, Samuel R.
  • REARICK, John P.
  • REESE, Brian E.
  • SCHMITT, Michael
  • SCHONEWALD, Stephanie L.
  • SHINALL, Michael A.
  • SHORE, David E.
  • SMITH, Maria C.
  • SUBRAMANIAN, Sowmya
  • SUH, Su Kyung
  • TSE, Janet M.
  • VETTER, Michael L.
  • VRABLIK, Tracy L.
  • ZHANG, Jialan
Priority Data
62/902,35318.09.2019US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) PLASMA KALLIKREIN INHIBITORS AND USES THEREOF
(FR) INHIBITEURS DE LA KALLICRÉINE PLASMATIQUE ET LEURS UTILISATIONS
Abstract
(EN) The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
(FR) La présente invention concerne des composés et des compositions de ceux-ci qui sont utiles en tant qu'inhibiteurs de la kallicréine plasmatique et qui présentent des caractéristiques souhaitables pour ceux-ci.
Related patent documents
EP2020785878This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
Latest bibliographic data on file with the International Bureau